These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9020052)

  • 1. Ribozyme and antisense RNAs inhibit coupled transcription translation by binding to rabbit polyribosomes.
    Denman RB
    Biochem Biophys Res Commun; 1997 Jan; 230(1):226-31. PubMed ID: 9020052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient hammerhead ribozyme and antisense RNA targeting in a slow ribosome Escherichia coli mutant.
    Chen H; Ferbeyre G; Cedergren R
    Nat Biotechnol; 1997 May; 15(5):432-5. PubMed ID: 9131620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
    Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
    Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitated reduction of beta-amyloid peptide precursor by synthetic oligonucleotides in COS-7 cells expressing a hammerhead ribozyme.
    Denman RB; Smedman M; Abraham M; Chen-Hwang MC; Currie JR
    Arch Biochem Biophys; 1997 Dec; 348(1):82-90. PubMed ID: 9390177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed cell death by hok/sok of plasmid R1: processing at the hok mRNA 3'-end triggers structural rearrangements that allow translation and antisense RNA binding.
    Franch T; Gultyaev AP; Gerdes K
    J Mol Biol; 1997 Oct; 273(1):38-51. PubMed ID: 9367744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The cleavage activity of GCV transfer vector-mediated hammerhead ribozyme for KRR1 in vitro transcript].
    Chen LF; Li JH; Zou YX; Zhao YP; Cao LL; Zhang XC
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Aug; 25(4):279-84. PubMed ID: 18038796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression.
    Wakita T; Moradpour D; Tokushihge K; Wands JR
    J Med Virol; 1999 Mar; 57(3):217-22. PubMed ID: 10022790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by suramin of protein synthesis in vitro. Ribosomes as the target of the drug.
    Brigotti M; Alfieri RR; Petronini PG; Carnicelli D
    Biochimie; 2006 May; 88(5):497-503. PubMed ID: 16386828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory mechanisms employed by cis-encoded antisense RNAs.
    Brantl S
    Curr Opin Microbiol; 2007 Apr; 10(2):102-9. PubMed ID: 17387036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and expression of chimeric U1/ribozyme transgenes.
    Abounader R; Montgomery R; Dietz H; Laterra J
    Methods Mol Biol; 2004; 252():209-19. PubMed ID: 15017051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-cleaving-ribozyme-mediated reduction of betaAPP in human rhabdomyosarcoma cells.
    Dolzhanskaya N; Conti J; Schwenk V; Merz G; Denman RB
    Arch Biochem Biophys; 2001 Mar; 387(2):223-32. PubMed ID: 11370845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.
    Scherr M; Reed M; Huang CF; Riggs AD; Rossi JJ
    Mol Ther; 2000 Jul; 2(1):26-38. PubMed ID: 10899825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The major cytoplasmic mRNP protein, p50, is required for efficient mRNA translation in vitro].
    Kovrigina EA; Nashchekin DV; Evdokimova VM; Ovchinnikov LP
    Biokhimiia; 1996 Dec; 61(12):2173-80. PubMed ID: 9156558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors altering ribozyme-mediated cleavage of tumor necrosis factor-alpha mRNA in vitro.
    Kisich KO; Freedland SJ; Erickson KL
    Biochem Biophys Res Commun; 1997 Jul; 236(1):205-11. PubMed ID: 9223453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.
    Mandava N; Blackburn P; Paul DB; Wilson MW; Read SB; Alspaugh E; Tritz R; Barber JR; Robbins JM; Kruse CA
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3338-48. PubMed ID: 12356843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa.
    Drenser KA; Timmers AM; Hauswirth WW; Lewin AS
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):681-9. PubMed ID: 9538873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
    Puerta-Fernandez E; Barroso-del Jesus A; Romero-López C; Berzal-Herranz A
    Biol Chem; 2003 Mar; 384(3):343-50. PubMed ID: 12715885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcription.
    DeMoor JM; Vincent MD; Collins OM; Koropatnick J
    Exp Cell Res; 1998 Aug; 243(1):11-21. PubMed ID: 9716444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinia core transcription prevents in vitro depolymerization of polyribosomes in rabbit reticulocyte lysate.
    Dâmaso CR; Moussatché N
    Braz J Med Biol Res; 1987; 20(6):763-6. PubMed ID: 3455255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antisense RNA inhibits translation by competing with standby ribosomes.
    Darfeuille F; Unoson C; Vogel J; Wagner EG
    Mol Cell; 2007 May; 26(3):381-92. PubMed ID: 17499044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.